Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in Malaysian subjects

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Al Hamodi, Zaid ^a   Saif Ali, Riyadh ^a,b   Ismail, Ikram S ^c   Ahmed, Khaled A ^d   Muniandy, Sekaran ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Department of Biochemistry   (Yemen)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^d IBB UNIVERSITY   (Yemen)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; DNA; SERPINE1 PROTEIN, HUMAN;

ADULT; ARTICLE; CORONARY RISK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALAYSIA; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; BLOOD; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; STATISTICAL MODEL;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; LOGISTIC MODELS; MALAYSIA; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84861057244     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/234937     Document Type: Article

References (30)

1. International Diabetes Federation Diabetes Atlas, http://www.eatlas.idf. org/prevalence/
2. Sadikot S. M., Mogensen C. E., Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study Diabetes Research and Clinical Practice 2008 82 3 391 395
3. Zimmet P., Alberti K. G. M. M., Shaw J., Global and societal implications of the diabetes epidemic Nature 2001 414 6865 782 787 (Pubitemid 34000780)
4. Alessi M. C., Juhan-Vague I., PAI-1 and the metabolic syndrome: links, causes, and consequences Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 10 2200 2207 (Pubitemid 44465712)
5. Eckel R. H., Grundy S. M., Zimmet P. Z., The metabolic syndrome The Lancet 2005 365 9468 1415 1428 (Pubitemid 40523737)
6. Al-Hamodi Z., Ismail I. S., Saif-Ali R., Ahmed K. A., Muniandy S., Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects Cardiovascular Diabetology 2011 10, article 6
7. Anna., Mechanisms and Effects of Low Plasminogen Activator Inhibitor Type 1 Activity 2008 Karolinska Institutet
8. Lopes C., Dina C., Durand E., Froguel P., PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population Diabetologia 2003 46 9 1284 1290 (Pubitemid 37214987)
9. Juhan-Vague I., Morange P. E., Aubert H., Henry M., Aillaud M. F., Alessi M. C., Samnegrd A., Hawe E., Yudkin J., Margaglione M., Di Minno G., Hamsten A., Humphries S. E., Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the North and South of Europe Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 5 867 873 (Pubitemid 34517803)
10. Mansfield M. W., Stickland M. H., Grant P. J., Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus Thrombosis and Haemostasis 1995 74 3 842 847
11. Freeman M., Mansfield M., To: J. Hoffstedt et al. (2002) The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity Diabetologia 2002 45 11 1602 1604 (Pubitemid 35352055)
12. Hoffstedt J., Andersson I. L., Persson L., Isaksson B., Arner P., The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity Diabetologia 2002 45 4 584 587 (Pubitemid 34533839)
13. Viitanen L., Pihlajamki J., Halonen P., Lehtonen M., Kareinen A., Lehto S., Laakso M., Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease Atherosclerosis 2001 157 1 57 64 (Pubitemid 32539354)
14. Tishkoff S. A., Ruano G., Kidd J. R., Kidd K. K., Distribution and frequency of a polymorphic Alu insertion at the plasminogen activator locus in humans Human Genetics 1996 97 6 759 764 (Pubitemid 26150845)
15. Novick G. E., Novick C. C., Yunis J., Yunis E., Antunez De Mayolo P., Scheer W. D., Deininger P. L., Stoneking M., York D. S., Batzer M. A., Herrera R. J., Polymorphic Alu insertions and the Asian origin of native American populations Human Biology 1998 70 1 23 39 (Pubitemid 28091516)
16. Alberti K. G. M. M., Zimmet P., Shaw J., The metabolic syndromea new worldwide definition The Lancet 2005 366 9491 1059 1062 (Pubitemid 41338752)
17. WHO, Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation 2006
18. Kang B. Y., Lee K. O., Genetic polymorphisms of t-PA and PAI-1 genes in the Korean population Korean Journal of Biological Sciences 2003 7 249 253
19. Wong T. Y. H., Poon P., Szeto C. C., Chan J. C. N., Li P. K. T., Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients Kidney International 2000 57 2 632 638 (Pubitemid 30430656)
20. Ezzidi I., Mtiraoui N., Chaieb M., Kacem M., Mahjoub T., Almawi W. Y., Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients Diabetes and Metabolism 2009 35 3 214 219
21. Nagi D. K., McCormack L. J., Mohamed-Ali V., Yudkin J. S., Knowler W. C., Grant P. J., Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes Diabetes Care 1997 20 8 1304 1309 (Pubitemid 27318377)
22. Broch M., Gutierrez C., Aguilar C., Simon I., Richart C., Vendrell J., Genetic variation in promoter (4G/5G) of plasminogen activator inhibitor 1 gene in type 2 diabetes. Absence of relationship with microangiopathy Diabetes Care 1998 21 3, article 463
23. Meigs J. B., O'Donnell C. J., Tofler G. H., Benjamin E. J., Fox C. S., Lipinska I., Nathan D. M., Sullivan L. M., D'Agostino R. B., Wilson P. W. F., Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study Diabetes 2006 55 2 530 537 (Pubitemid 43343286)
24. Zietz B., Buechler C., Drobnik W., Herfarth H., Schlmerich J., Schffler A., Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels Endocrine Research 2004 30 3 443 453 (Pubitemid 39453091)
25. Kimura H., Gejyo F., Suzuki Y., Suzuki S., Miyazaki R., Arakawa M., Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy Kidney International 1998 54 5 1659 1669 (Pubitemid 28502908)
26. Meigs J. B., Dupuis J., Liu C., O'Donnell C. J., Fox C. S., Kathiresan S., Gabriel S. B., Larson M. G., Yang Q., Herbert A. G., Wilson P. W. F., Feng D., Tofler G. H., Cupples L. A., PAI-1 gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample Obesity 2006 14 5 753 758 (Pubitemid 46219713)
27. Al-Hamodi Z. H., Saif-Ali R., Ismail I. S., Ahmed K. A., Muniandy S., Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian Subjects. Journal of Clinical Biochemistry and Nutrition. In press
28. Ahmed W., Malik M., Saeed I., Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction Molecular Biology Reports 2011 38 4 2541 2548
29. Lovrecic L., Ristic S., Starcevic-Cizmarevic N., PAI and TPA gene polymorphisms in multiple sclerosis Multiple Sclerosis 2008 14 2 243 247 (Pubitemid 351639634)
30. Gurkan A., Emingil G., Saygan B. H., Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis Journal of Periodontology 2007 78 7 1256 1263